Medical Devices & Tech

Bacterin International Holdings, Inc.

600 Cruiser Lane
Belgrade, MT 59714 USA
Click for website

Research Sector Medical Devices & Tech

Summary Description Bone graft material and anti-infective coatings for medical applications

Management Daniel S. Goldberger, CEO; John Gandolfo, CFO; Darrel L. Holmes, COO; Robert Di Silvio, President; Gregory A. Juda, Ph.D., Chief Scientific Officer

Click here for Financial Data
Keywords: wound, woundcare, orthopedic, medical device, skin, dermal, cartilage, grafts, tissue, regeneration, stem cells, bone, skin, healing


Updated: Mar. 18, 2016


Bacterin International Holdings Inc. develops anti-microbial, anti-infective coatings for revolutionary bone graft material and also processes and markets innovative, biologic allografts for transplan......view more

Products / Services

Bacterin's products are divided into three main areas: biologic products, medical devices, and coating technologies. The biologic products focus on human allografts for transplantation, featuring: Ost......view more

Technology / Differentiation

OsteoSponge is a unique graft material designed to augment the handling properties of bone through a patent pending process. Its porous structure provides an excellent matrix for vascular growth and n...view more

Market / Customers

Bacterin's products have various applications in orthopedic, neurological, trauma, oral/maxillofacial and reconstructive procedures. The allograft market is valued at $1 billion and is growing at 15-2......view more

Revenue / Funding

The Pentagon has given Bacterin $1.4 million to fight infections by coating the metal rods and pins used to treat arm and leg wounds on the battlefield....view more


Bacterin received the 2009 Spine Technology Award in the Regenerative Technology Category for the proprietary biologic scaffold OsteoSponge Demineralized Bone Matrix. In 2007, Bacterin was awarded a p...view more